The Globe and Mail reports in its Tuesday, Dec. 5, edition that DA Davidson analyst Brandon Rolle has reaffirmed his "buy" call for BRP. The Globe's David Leeder writes that Mr. Rolle slashed his share target by $27 to $99. Analysts on average target the shares at $103.28. Mr. Rolle recommends buying BRP on weakness. Mr. Rolle says in a note: "[BRP's] updated guidance implies another challenging quarter in 4Q24 from both a revenue and EPS growth perspective. The company indicated 3Q24 ORV retail started to see a material slowdown in October which has continued throughout November. In addition, BRP's FY25 targets will be postponed as macroeconomic factors and a looming inventory rationalization period has negatively impacted their FY25 outlook. Although the company is still working through their official FY25 guidance, BRP did provide early FY25 assumptions of revenue down a low-to-mid-single digits year-over-year with EBITDA margins contracting 100-200 basis points year-over-year." The Globe reported on April 5 that Mr. Rolle had lowered his recommendation for BRP to "neutral" from "buy." It was then worth $98.21. The Globe reported on June 14 that Mr. Rolle continued to rate BRP "buy." It was then worth $105.55.